Os Therapies Incorporated
(OSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,017 | -1,459 | -7,792 | -6,327 | -4,352 |
| Depreciation Amortization | 1,089 | 1 | 2,651 | 2,437 | 1,453 |
| Accounts payable and accrued liabilities | -46 | 42 | 1,348 | 1,116 | 1,258 |
| Other Working Capital | 405 | 238 | 2,017 | 1,637 | 1,523 |
| Other Operating Activity | 46 | 537 | -1,231 | -1,000 | -1,141 |
| Operating Cash Flow | $-1,523 | $-642 | $-3,007 | $-2,136 | $-1,259 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 1 | 1 | 1 |
| Investing Cash Flow | $N/A | $N/A | $1 | $1 | $1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 250 | N/A | N/A | N/A | N/A |
| Debt Issued | 1,501 | 751 | 3,158 | 2,088 | 1,263 |
| Other Financing Activity | -172 | -48 | -285 | -108 | -127 |
| Financing Cash Flow | $1,579 | $703 | $2,873 | $1,979 | $1,136 |
| Beginning Cash Position | 39 | 39 | 172 | 172 | 172 |
| End Cash Position | 95 | 100 | 39 | 16 | 49 |
| Net Cash Flow | $56 | $61 | $-133 | $-155 | $-122 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,523 | -642 | -3,007 | -2,136 | -1,259 |
| Free Cash Flow | -1,523 | -642 | -3,007 | -2,136 | -1,259 |